Hisashi Umeoka - Taisho Pharmaceutical Director

Insider

Hisashi Umeoka is Director of Taisho Pharmaceutical Holdings
Phone81 3 3985 2020
Webhttps://www.taisho-holdings.co.jp

Taisho Pharmaceutical Management Efficiency

The company has return on total asset (ROA) of 0.0183 % which means that it generated a profit of $0.0183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0345 %, meaning that it generated $0.0345 on every $100 dollars invested by stockholders. Taisho Pharmaceutical's management efficiency ratios could be used to measure how well Taisho Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Marcela KirbergerElanco Animal Health
57
Karen SmithEmergent Biosolutions
52
Gunupati BEDr Reddys Laboratories
65
Mukesh RathiDr Reddys Laboratories
45
Scott FergusonElanco Animal Health
46
Robert SrEmergent Biosolutions
67
Deepak MBADr Reddys Laboratories
50
Joyce LeeElanco Animal Health
47
Jennifer FoxEmergent Biosolutions
51
David BaylesViatris
N/A
Brian RomanViatris
55
Jonathan MDPacira BioSciences,
50
Lynn KiefferEmergent Biosolutions
N/A
Amy LanducciHaleon plc
N/A
Dirk EhleElanco Animal Health
50
Keith KatkinEmergent Biosolutions
48
Roy MDPacira BioSciences,
62
Galia InbarTeva Pharma Industries
N/A
Amir WeissTeva Pharma Industries
48
MBA MBADr Reddys Laboratories
55
Tamara RogersHaleon plc
55
Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter drugs and prescription pharmaceutical products in Japan and internationally. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan. Taisho Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 9134 people. Taisho Pharmaceutical Holdings [TAIPY] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Taisho Pharmaceutical Leadership Team

Elected by the shareholders, the Taisho Pharmaceutical's board of directors comprises two types of representatives: Taisho Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taisho. The board's role is to monitor Taisho Pharmaceutical's management team and ensure that shareholders' interests are well served. Taisho Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taisho Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Shigeru Uehara, Vice President and Presidentident of Subsidiary, Director
Shinichi Tanaka, Gen Communications
Akira Uehara, President Chairman of Subsidiary, Representative Director
Jinsei Maruyama, Co Officer
Tetsu Watanabe, Executive Director
Jun Kuroda, Ex Director
Ken Uehara, MD Director
Hideki Iuchi, G Mang
Hisashi Umeoka, Director

Taisho Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Taisho Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Consideration for investing in Taisho Pink Sheet

If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios